Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
116-hr-5381116th Congress
International Pharmaceutical Transparency Act of 2019
Sponsored By: Representative DesJarlais, Scott [R-TN-4]
Unknown
Summary
International Pharmaceutical Transparency Act of 2019 This bill prohibits the sale of a drug if its label fails to list the country of origin of each of the drug's active ingredients.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
DesJarlais, Scott [R-TN-4]
TN • R
Cosponsors
There are no cosponsors for this bill.
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov